Skip to main content
SpringerLink
Log in

Cellular immunotherapy: antigen recognition is just the beginning

  • Original Article
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

Advances in molecular and cellular biology have illustrated both the flexibility and complexity involved in host immune responses. Understanding this response is vital to the further development of therapeutic strategies that involve manipulation of the cellular immune response to target tumors. Mobilized, tumor antigen-specific T cells, the core for most immunotherapeutic strategies, are highly regulated, and capable of a wide spectrum of functional responses. Due to differences in murine and human immunity, broad-scale immune monitoring, particularly high-throughput ex vivo analysis of human immune responses, promises to determine what comprises an effective immunotherapy. Such understanding will lead to more sophisticated clinical trials, earlier determination of efficacy and individualized protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Altman JD, Moss PA, Goulder PJ, et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94

    Google Scholar 

  2. Antonia S, Mule JJ, Weber JS (2004) Current developments of immunotherapy in the clinic. Curr Opin Immunol 16:130

    Google Scholar 

  3. Applegate KG, Balch CM, Pellis NR (1990) In vitro migration of lymphocytes through collagent matrix: arrested locomotion in tumor-infiltrating lymphocytes. Cancer Res 50:7153

    Google Scholar 

  4. Bachmann MF, Barner M, Viola A, et al (1999) Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 29:291

    Google Scholar 

  5. Baecher-Allan C, Viglietta V, Hafler DA (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16:89

    Google Scholar 

  6. Bernabei P, Coccia EM, Rigamonti L, et al (2001) Interferon-gamma receptor 2 expression as the deciding factor in human T, B and myeloid cell proliferation or death. J Leukoc Biol 70:950

    Google Scholar 

  7. Beutler BA (1999) The role of tumor necrosis factor in health and disease. J Rheumatol Suppl 57:16

    Google Scholar 

  8. Biron CA (2001) Interferons alpha and beta as immune regulators—a new look. Immunity 14:661

    Google Scholar 

  9. Chen DS, Soen Y, Davis MM, Brown PO (2004) Functional and molecular profiling of heterogeneous tumor samples using a novel cellular microarray. Journal of Clinical Oncology 22:9507

    Google Scholar 

  10. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860

    Google Scholar 

  11. Davis MM, Boniface JJ, Reich Z (1998) Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16:523

    Google Scholar 

  12. Eklund JW, Kuzel TM (2004) A review of recent findings involving interleukin-2-based cancer therapy. Curr Opin Oncol 16:542

    Google Scholar 

  13. Groettrup M, Khan S, Schwarz K, et al (2001) Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83:367

    Google Scholar 

  14. Hecht I, Cahalon L, Hershkoviz R, et al (2003) Heterologous desensitization of T cell function by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis. Int Immunol 15:29

    Google Scholar 

  15. Horwitz DA, Zheng SG, Gray JD, et al (2004) Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol 16:135

    Google Scholar 

  16. Kwon B, Kim BS, Cho HR, et al (2003) Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35:8

    Google Scholar 

  17. Lee PP, Yee C, Savage PA, et al (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 5:677

    Google Scholar 

  18. Lee P, Wang F, Kuniyoshi J, et al (2001) Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma. J Clin Oncol 19:3836

    Google Scholar 

  19. Lehner PJ, Cresswell P (2004) Recent developments in M class I-mediated antigen presentation. Curr Opin Immunol 16:82

    Google Scholar 

  20. Lejeune FJ, Ruegg C, Lienard D (1998) Clinical applications of TNF-alpha in cancer. Curr Opin Immunol 10:573

    Google Scholar 

  21. Lim DG, Bieganowska Bourcier K, Freeman GJ, et al (2000) Examination of CD8+ T cell function in humans using MHC class I tetramers: similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope. J Immunol 165:6214

    Google Scholar 

  22. Malek TR, Bayer AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4:665

    Google Scholar 

  23. Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731

    Google Scholar 

  24. Mills KH (2004) Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4:841

    Google Scholar 

  25. Muller WJ, Sinn E, Pattengale PK, et al (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105

    Google Scholar 

  26. Naka T, Nishimoto N, Kishimoto T (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4 Suppl 3: S233

  27. Nandi A, Estess P, Siegelman M (2004) Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20:455

    Google Scholar 

  28. Negulescu PA, Krasieva TB, Khan A, et al (1996) Polarity of T cell shape, motility, and sensitivity to antigen. Immunity 4:421

    Google Scholar 

  29. Paul WE (2003) Fundamental Immunology. Lippincott, Williams & Wilkins, Philadelphia

  30. Prevost-Blondel A, Roth E, Rosenthal FM, et al (2000) Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lew lung carcinoma cells in vivo. J Immunol 164:3645

    Google Scholar 

  31. Purbhoo MA, Irvine DJ, Huppa JB, et al (2004) T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 5:524

    Google Scholar 

  32. Raja SM, Metkar SS, Froelich CJ (2003) Cytotoxic granule-mediated apoptosis: unraveling the complex mechanism. Curr Opin Immunol 15:528

    Google Scholar 

  33. Rosenberg SA (2001) Progress in human tumour immunology and immunotherapy. Nature 411:380

    Google Scholar 

  34. Rosenwasser LJ (1998) Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 102:344

    Google Scholar 

  35. Schmittel A, Keilholz U, Thiel E, et al (2000) Quantification of tumor-specific T lymphocytes with the ELISPOT assay. J Immunother 23:289

    Google Scholar 

  36. Schroder K, Hertzog PJ, Ravasi T, et al (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163

    Google Scholar 

  37. Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944

    Google Scholar 

  38. Soen Y, Chen DS, Kraft DL, et al (2003) Detection and characterization of cellular immune responses using peptide-MHC microarrays. PLoS Biol 1:E65

    Google Scholar 

  39. Soen Y, Chen DS, Stuge T, et al (2003) A novel cellular microarray identifies functional deficiencies in tumor-specific T cell responses. Journal of Clinical Oncology 22:2510

    Google Scholar 

  40. Taams LS, Eden W van, Wauben MH (1999) Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur J Immunol 29:1543

    Google Scholar 

  41. Tracey KJ, Beutler B, Lowry SF, et al (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470

    Google Scholar 

  42. Whiteside TL, Zhao Y, Tsukishiro T, et al (2003) Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma. Clin Cancer Res 9:641

    Google Scholar 

  43. Zippelius A, Batard P, Rubio-Godoy V, et al (2004) Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res 64:2865

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Oncology, Stanford University, Stanford, California, USA

    Daniel S. Chen

  2. Department of Microbiology & Immunology, Stanford University, Stanford, CA, 94305-5124, USA

    Daniel S. Chen & Mark M. Davis

  3. Howard Hughes Medical Institute, Stanford University, Stanford, California, USA

    Daniel S. Chen & Mark M. Davis

Authors
  1. Daniel S. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark M. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark M. Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, D.S., Davis, M.M. Cellular immunotherapy: antigen recognition is just the beginning. Springer Semin Immun 27, 119–127 (2005). https://doi.org/10.1007/s00281-005-0200-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-005-0200-z

Keywords

Search

Navigation